MedTrace Logo

SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization

NCT06550024 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2026-03-18

No results posted yet for this study

Summary

An open label, prospective, two-arm, multicenter, randomized controlled trial comparing SakuraBead genicular artery embolization (GAE) with a control (corticosteroid injection).

Conditions

Interventions

DEVICE

SakuraBead Resorbable Microspheres

Temporary Embolization of Genicular Arteries using SakuraBead Resorbable Microspheres

DRUG

Corticosteroid Injection

Corticosteroid injection in the knee

Sponsors & Collaborators

  • CrannMed

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-28
Primary Completion
2026-10-31
Completion
2028-10-31
FDA Device
Yes

Countries

  • United States
  • Georgia
  • United Kingdom
  • Uzbekistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06550024 on ClinicalTrials.gov